Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non‐alcoholic fatty liver disease - Chun, Ho Soo; Lee, Minjong; Lee, Jae Seung; Lee, Hye Won; Kim, Beom Kyung; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Lee, Yong‐Ho; Kim, Ji‐Hye; Kim, Seung Up (Liver international, 2023)
Keywords: Arteriosclerosis; Aspartate aminotransferase; Aspartate Aminotransferases; Atherosclerosis; cardiovascular disease; Cardiovascular Diseases; Fatty liver; Fibrosis; Health risks; Heart Disease Risk Factors; Heart diseases; Humans; Liver; Liver Cirrhosis; Liver diseases; liver fibrosis; metabolic dysfunction‐associated fatty liver disease; Metabolism; Non-alcoholic Fatty Liver Disease; Population studies; Risk Factors; Subgroups; Transaminases; cardiovascular disease; liver fibrosis; metabolic dysfunction-associated fatty liver disease; non-alcoholic fatty liver disease